Browsing by Author Shoemake, Claire

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 18 to 29 of 29 < previous 
Issue DateTitleAuthor(s)
2015Generating a homology model of the human M1 muscarinic receptor and the design of cognate modulators at this locus for the management of Alzheimer’s diseaseBugeja, Neil J.; Shoemake, Claire
2016-07Identification of lead molecules capable of the simultaneous agonism of the PPARƴ and PPARα subtypes for the dual management of diabetes mellitus and dyslipidaemiaEllul, Claire; Shoemake, Claire
2014In silico identification of a potentially novel binding modality for 1,3-dicarbonyl compounds having 2(3h)-benzazolonic heterocycles within the pparγ ligand binding pocket : a de novo design studyPortelli, Stephanie; Shoemake, Claire; Azzopardi, Lilian M.
2009-11Investigating the angiotensin converting enzyme (ACE) inhibiting properties of naturally occurring terpenes using in silico modelsMifsud, S. J.; Shoemake, Claire; Attard, Everaldo; Sant Fournier, Marianne; Azzopardi, Lilian M.
2013Investigating the anti-oestrogenic effect of p-Synephrine and de novo design of oestrogen receptor modulating moleculesPace Bardon, C.; Shoemake, Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2013-02-28Investigative study on the angiotensin converting enzyme (ACE) inhibiting properties of the terpenoid extract of Crataegus monogyna using in silico modelsFarrugia, Deborah Louise; Shoemake, Claire; Attard, Everaldo; Azzopardi, Lilian M.; Mifsud, S. J.
2013Labelling and testing of foods designated as suitable for diabetic and low calorie dietsCordina, Jakov; Shoemake, Claire; Azzopardi, Lilian M.
2013De novo design of non-steroidal oestrogen receptor modulating molecules using maltanedienol as a lead moleculeShoemake, Claire; Azzopardi, Lilian M.; Saliba, Charles; Gutierrez, Gilles; Cassar, Maria
2012Optimisation of abiraterone based non-steroidal lead moleculesGrima, A.; Shoemake, Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2012Optimisation of Tyrosine-based lead molecules capable of Modulation of the Peroxisome Proliferator-Activated Receptor GammaCiantar, J.; Shoemake, Claire; Mangani, C.; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2016Optimization of in silico designed fatty acid synthase modulators derived from the lead molecule orlistatShoemake, Claire; Sciberras, R.
2015A structure-based drug design approach for the identification of novel selective Cyclooxygenase-2 inhibitors using resveratrol analogues as lead moleculesCaruana, Clarissa; Shoemake, Claire